The dental biomaterials market has seen considerable growth due to a variety of factors.
• The market for dental biomaterials has seen robust growth in recent times. Evidently, the market which was valued at $8.49 billion in 2024 is projected to rise to $9.11 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. This significant growth in the past period is largely due to the advent of CAD/CAM, advancements made in periodontal therapies, growth in endodontic treatments, the development of dental adhesive technology, as well as the introduction of dental implants.
The Dental Biomaterials market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for dental biomaterials is projected to experience significant growth in the upcoming years, reaching a value of $12.71 billion in 2029 with an 8.7%.
compound annual growth rate (CAGR). This expansion during the prediction period can be linked to the rising preference for digital dentistry, the escalating demand for cosmetic dentistry, an increase in the elderly population and dental implant procedures, a concentration on less invasive methods, and the need for environmentally friendly and biocompatible materials. Key trends for the forecast period involve customized dentistry and solutions tailored to individual patients, sustainability and biocompatibility, increasing demand for aesthetic and functional repairs, and a focus on regenerative dentistry.
Gain Insights Into The Dental Biomaterials Global Market Report 2025 With A Free Sample Report Here:
The escalating occurrence of dental diseases is anticipated to boost the growth of the dental biomaterials market in the future. These diseases are harmful to the mouth and oral cavity. Dental biomaterials offer valuable solutions for these dental conditions by delivering extra protection, remineralization, and proactive prevention of dental issues. Subsequently, the escalating prevalence of dental conditions enhances the demand for the dental biomaterials market. For example, the World Health Organization (a global agency of the United Nations striving to improve health) stated in March 2022 that nearly 3.5 billion people worldwide are afflicted with oral disorders. Permanent tooth caries is cited as the most common disease. It is estimated that 520 million children around the globe are affected by primary tooth decay, while 2 billion adults suffer from permanent tooth decay. Worldwide, there are 4 occurrences of lip and oral cavity cancer per 100,000 individuals. Consequently, the escalating prevalence of dental diseases bolsters the dental biomaterials marketplace.
The dental biomaterials market covered in this report is segmented –
1) By Type: Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials, Natural Biomaterials, Composites Biomaterials
2) By Bone Graft Material Type: Allograft, Xenograft, Synthetic
3) By Application: Orthodontics, Implantology, Prosthodontics, Other Applications
4) By End-User: Dental Hospitals And Clinics, Dental Laboratories, Dental Academies And Research Institutes, Dental Product Manufacturers
Subsegments:
1) By Metallic Biomaterials: Stainless Steel, Titanium Alloys, Cobalt-Chromium Alloys
2) By Ceramic Biomaterials: Alumina, Zirconia, Calcium Phosphate Ceramics
3) By Polymeric Biomaterials: Polyethylene, Polymethyl Methacrylate (PMMA), Polyurethane
4) By Metal-Ceramic Biomaterials: Porcelain-Fused-To-Metal (PFM), Metal-Ceramic Composites
5) By Natural Biomaterials: Collagen, Chitosan, Hydroxyapatite
6. By Composites Biomaterials: Resin Composites, Glass Ionomer Composites
The rise of technological progression is an emerging trend within the dental biomaterials market. Leading corporations within the sector are focusing on thorough research and development to produce ground-breaking products which offer various benefits and contribute towards better yield. These kind of innovation helps companies to gain a competitive advantage. For instance, during February 2023, Nobel Biocare, a Swiss-based dental implants producer, collaborated with Mimetis Biomaterials S.L, a Spanish company specialized in designing, manufacturing, and marketing bone regeneration solutions, to launch the brand-new creos syntogain biomimetic bone graft substitute. This novel generation of synthetic bone grafts consists of 80% Calcium Deficient Hydroxyapatite (CDHA) and 20% of ß-TCP (beta-tricalcium phosphate), designed to resemble human bone which is also composed of CDHA. The more a material replicates human bone, the more effective it is for bone formation.
Major companies operating in the dental biomaterials market include:
• Straumann Group
• Geistlich Biomaterials
• Zimmer Biomet Holdings Inc.
• Dentsply Sirona Inc.
• 3M Company
• Koninklijke DSM N.V.
• Kuraray Co Ltd.
• Henry Schein Inc.
• Mitsui Chemicals Inc.
• Ivoclar Vivadent AG
• Bego Medical GmbH
• Institut Straumann AG
• BioHorizons IPH Inc.
• Nobel Biocare Services AG
• ACE Surgical Supply Company Inc.
• Biomatlante
• Align Technology Inc.
• Carestream Dental LLC
• Datum Dental Ltd.
• VITA Zahnfabrik H Rauter Gr KG
• Coltene Whaledent AG
• DMG Chemisch-Pharmazeutische Fabrik GmbH
• Heraeus Kulzer GmbH
• Kavo Dental GmbH
• Septodont Holding
• Ultradent Products Inc.
• VOCO GmbH
North America was the largest region in the dental biomaterials market share in 2024. The regions covered in the dental biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.